Back to Russell Investments Group, Ltd. Russell Investments Group, Ltd.

EGRXEGRX
26 quarters

Position history for Russell Investments Group, Ltd.Russell Investments Group, Ltd.'s holdings in EAGLE PHARMACEUTICALS INC

No. Russell Investments Group exited its EGRX (Eagle Pharmaceuticals) position in Q1 2025. Its Q4 2024 13F listed 3,411 shares worth $1,706. Russell Investments Group already held EGRX in its Q4 2018 13F, the earliest on record, and held it in 25 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$576,000

Total Shares Change

-14,307

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$0.88
0
2024-Q4
Decreased
3,411
-4.2%
$1,7060.0%$0.50
0
2024-Q3
Decreased
3,561
-63.7%
$13,2830.0%$3.95
0
2024-Q2
Increased
9,798
+323.8%
$54,8680.0%$5.60
33
2024-Q1
Decreased
2,312
-83.7%
$12,1150.0%$5.24
0
2023-Q4
Decreased
14,140
-8.6%
$73,9490.0%$5.23
0
2023-Q3
Increased
15,465
+2418.7%
$243,8820.0%$15.77
37
2023-Q2
Decreased
614
-82.4%
$11,9350.0%$19.47
0
2023-Q1
Decreased
3,493
-66.1%
$99,0960.0%$27.88
0
2022-Q4
Increased
10,293
+194.7%
$300,8640.0%$29.23
38
2022-Q3
Decreased
3,493
-45.6%
$92,0000.0%$28.60
0
2022-Q2
Decreased
6,426
-41.6%
$283,0000.0%$43.12
0
2022-Q1
Decreased
11,013
-15.9%
$543,0000.0%$49.50
0
2021-Q4
Decreased
13,096
-31.3%
$664,0000.0%$51.10
0
2021-Q3
Decreased
19,068
-55.6%
$1.1M0.0%$55.09
0
2021-Q2
Decreased
42,913
-56.0%
$1.8M0.0%$42.14
0
2021-Q1
Increased
97,533
+14.5%
$4.1M0.0%$41.06
30
2020-Q4
Decreased
85,212
-7.3%
$4M0.0%$46.50
0
2020-Q3
Increased
91,888
+2.6%
$3.9M0.0%$41.88
27
2020-Q2
Increased
89,535
+36.7%
$4.3M0.0%$48.02
35
2020-Q1
Increased
65,495
+15.5%
$3M0.0%$45.31
30
2019-Q4
Decreased
56,692
-19.8%
$3.4M0.0%$59.89
0
2019-Q3
Increased
70,664
+77.3%
$4M0.0%$56.43
41
2019-Q2
Increased
39,845
+75.9%
$2.2M0.0%$55.68
39
2019-Q1
Increased
22,655
+58.4%
$1.1M0.0%$50.49
36
2018-Q4
First report
14,307
-
$576,0000.0%$39.23
0

Other major holders of EGRX: Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used